Advertisement
Screener

Octagon Capital Advisors LP Historic Quarter Change: USA Other Stocks, Sold Out

Octagon Capital Advisors LP historic quarter change: USA Other Stocks, Sold out

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, Octagon Capital Advisors LP opened 10 positions, added to 5, reduced 2 and sold out of 20.

  • Q2 2025: Stock REGULUS THERAPEUTICS INC; Country of operation United States; Class COM; Shares before 4,637,076.
  • Q2 2025: Stock UNICYCIVE THERAPEUTICS INC; Country of operation United States; Class COM; Shares before 10,000,000.
  • Q1 2025: Stock ALLOVIR INC; Country of operation United States; Class COM; Shares before 11,215,000.
  • Q1 2025: Stock MERSANA THERAPEUTICS INC; Country of operation United States; Class COM; Shares before 992,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1839435), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-16); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2020-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2025REGULUS THERAPEUTICS INC
CUSIP 75915K309
United StatesCOM4,637,0760-4,637,076$8,114,883$0-$8,114,8832025-08-14
Q2 2025UNICYCIVE THERAPEUTICS INC
CUSIP 90466Y103
United StatesCOM10,000,0000-10,000,000$5,749,000$0-$5,749,0002025-08-14
Q1 2025ALLOVIR INC
CUSIP 019818202
United StatesCOM11,215,0000-11,215,000$4,710,300$0-$4,710,3002025-05-16
Q1 2025MERSANA THERAPEUTICS INC
CUSIP 59045L106
United StatesCOM992,0000-992,000$1,418,560$0-$1,418,5602025-05-16
Q4 2024ALLOVIR INC
CUSIP 019818103
United StatesCOM11,202,0000-11,202,000$9,056,817$0-$9,056,8172025-02-14
Q4 2024RENEO PHARMACEUTICALS INC
CUSIP 75974E103
United StatesCOM2,250,0000-2,250,000$3,825,000$0-$3,825,0002025-02-14
Q4 2024AEROVATE THERAPEUTICS INC
CUSIP 008064107
United StatesCOM465,4400-465,440$972,770$0-$972,7702025-02-14
Q4 2024RAPT THERAPEUTICS INC
CUSIP 75382E109
United StatesCOM292,0000-292,000$586,920$0-$586,9202025-02-14
Q3 2024POSEIDA THERAPEUTICS INC
CUSIP 73730P108
United StatesCOM736,0000-736,000$2,149,120$0-$2,149,1202024-11-14
Q3 2024ELEVATION ONCOLOGY INC
CUSIP 28623U101
United StatesCOM747,0000-747,000$2,016,900$0-$2,016,9002024-11-14
Q3 2024ADICET BIO INC
CUSIP 007002108
United StatesCOM767,7990-767,799$929,037$0-$929,0372024-11-14
Q2 2024ALPINE IMMUNE SCIENCES INC
CUSIP 02083G100
United StatesCOM1,241,3000-1,241,300$49,205,132$0-$49,205,1322024-08-14
Q2 2024PERSPECTIVE THERAPEUTICS INC
CUSIP 46489V104
United StatesCOM14,718,4220-14,718,422$17,514,922$0-$17,514,9222024-08-14
Q2 2024GLYCOMIMETICS INC
CUSIP 38000Q102
United StatesCOM3,000,0000-3,000,000$9,000,000$0-$9,000,0002024-08-14
Q2 2024VINCERX PHARMA INC
CUSIP 92731L106
United StatesCOM NEW1,000,0000-1,000,000$5,060,000$0-$5,060,0002024-08-14
Q2 2024VERU INC
CUSIP 92536C103
United StatesCOM3,800,0000-3,800,000$2,660,380$0-$2,660,3802024-08-14
Q1 2024CYMABAY THERAPEUTICS INC
CUSIP 23257D103
United StatesCOM2,673,7500-2,673,750$63,153,975$0-$63,153,9752024-05-15
Q1 2024JASPER THERAPEUTICS INC
CUSIP 471871103
COM4,468,1140-4,468,114$3,525,342$0-$3,525,3422024-05-15
Q1 2024INOZYME PHARMA INC
CUSIP 45790W108
United StatesCOM400,0000-400,000$1,704,000$0-$1,704,0002024-05-15
Q1 2024XILIO THERAPEUTICS INC
CUSIP 98422T100
United StatesCOM1,785,0000-1,785,000$981,750$0-$981,7502024-05-15

Similar Firms

Firm NameCountry13F ValueHoldings
AWM Investment Company, Inc.United States$0.903B98
Asset One Wealth Management LLCUnited States$0.904B336
Sendero Wealth Management, LLCUnited States$0.904B321
EnCap Investments L.P.United States$0.905B4
Permian Investment Partners, LPUnited States$0.905B13
Per Stirling Capital Management, LLC.United States$0.905B310
EVERMAY WEALTH MANAGEMENT LLCUnited States$0.902B594
PERISCOPE CAPITAL INC.Canada$0.902B429
Hill Investment Group Partners, LLCUnited States$0.906B50
Redhawk Wealth Advisors, Inc.United States$0.906B387